Showing results (41-50 of 310) with videos related to

Sort By:
Pageof 31
World Journal of Gastroenterology|February 23, 2016
Gut microbiota role in irritable bowel syndrome: New therapeutic strategiesEleonora Distrutti, Lorenzo Monaldi, Patrizia Ricci, et al.
Future Medicinal Chemistry|May 11, 2012
Farnesoid X receptor: from medicinal chemistry to clinical applicationsStefano Fiorucci, Andrea Mencarelli, Elenora Distrutti, et al.
Expert Opinion on Therapeutic Patents|April 14, 2018
Farnesoid X receptor modulators 2014-present: a patent reviewValentina Sepe, Eleonora Distrutti, Stefano Fiorucci, et al.
Expert Opinion on Therapeutic Patents|July 18, 2015
Farnesoid X receptor modulators (2011 - 2014): a patent reviewValentina Sepe, Eleonora Distrutti, Stefano Fiorucci, et al.
Biochimica Et Biophysica Acta|April 28, 2009
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophagesBarbara Renga, Marco Migliorati, Andrea Mencarelli, et al.
Journal of Lipid Research|September 29, 2009
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese ratsSabrina Cipriani, Andrea Mencarelli, Giuseppe Palladino, et al.
Frontiers in Immunology|August 29, 2018
Bile Acids Activated Receptors Regulate Innate ImmunityStefano Fiorucci, Michele Biagioli, Angela Zampella, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Obeticholic Acid and Other Farnesoid-X-Receptor (FXR) Agonists in the Treatment of Liver DisordersStefano Fiorucci, Ginevra Urbani, Eleonora Distrutti, et al.
Progress in Lipid Research|November 26, 2009
Bile acid-activated receptors in the treatment of dyslipidemia and related disordersStefano Fiorucci, Sabrina Cipriani, Franco Baldelli, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 26, 2008
Antiatherosclerotic effect of farnesoid X receptorAndrea Mencarelli, Barbara Renga, Eleonora Distrutti, et al.
Pageof 31